Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?
- PMID: 28207965
- DOI: 10.1111/ped.13265
Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?
Abstract
Background: Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome is the most frequent repetitive fever syndrome in childhood. It is characterized by fever episodes lasting for approximately 3-6 days, once every 3-8 weeks.
Methods: Clinical and laboratory data for PFAPA syndrome patients between January 2010 and December 2014 followed up at a tertiary pediatric care hospital were reviewed.
Results: Four hundred children (256 male, 144 female; mean age at diagnosis, 4.2 ± 2.2 years), were enrolled in the study. During the episodes, mean leukocyte number was high (12 725/mm3 ) with predominant neutrophils. The mean number of monocytes was 1256/mm3 , and 90.2% had monocytosis. Serum amyloid A and C-reactive protein were high in 84.6% and in 77.8% of the patients, respectively. Mediterranean fever (MEFV) gene heterozygous mutation was identified in 57 of the 231 patients (24.7%) in whom genetic analysis had been performed. The most frequent mutation was heterozygous M694V (10%, n = 23). Extension of between-episode interval following prophylaxis was noted in 85% of those on regular colchicine treatment (n = 303). In the colchicine group, between-episode interval was prolonged from 18.8 ± 7.9 days (before colchicine treatment) to 49.5 ± 17.6 days on prophylactic colchicine therapy; also, prophylactic treatment was more effective in reducing episode frequency in patients with MEFV gene variant (n = 54, 96%) than in those without (n = 122, 80%; P = 0.003).
Conclusions: This study has involved the largest number of PFAPA syndrome patients in the literature. It is particularly important to assess and to demonstrate the high rate of response to colchicine prophylaxis in PFAPA syndrome patients, especially those with MEFV variant. On blood screening, neutrophilia associated with monocytosis and low procalcitonin could contribute to diagnosis.
Keywords: MEFV; PFAPA syndrome; child; colchicine; periodic fever.
© 2017 Japan Pediatric Society.
Similar articles
-
Gray zone in the spectrum of autoinflammatory diseases: familial Mediterranean fever accompanying periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: single-center experience.Eur J Pediatr. 2023 Dec;182(12):5473-5482. doi: 10.1007/s00431-023-05209-4. Epub 2023 Sep 30. Eur J Pediatr. 2023. PMID: 37777601
-
Could familial Mediterranean fever gene mutations be related to PFAPA syndrome?Pediatr Allergy Immunol. 2016 Feb;27(1):78-82. doi: 10.1111/pai.12490. Epub 2015 Oct 20. Pediatr Allergy Immunol. 2016. PMID: 26360812
-
Does having MEFV gene sequence variants affect the clinical course and colchicine response in children with PFAPA syndrome?Eur J Pediatr. 2023 Jan;182(1):411-417. doi: 10.1007/s00431-022-04709-z. Epub 2022 Nov 15. Eur J Pediatr. 2023. PMID: 36376520 Free PMC article.
-
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome.Clin Dermatol. 2016 Jul-Aug;34(4):482-6. doi: 10.1016/j.clindermatol.2016.02.021. Epub 2016 Mar 2. Clin Dermatol. 2016. PMID: 27343963 Review.
-
Recurrence of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome after tonsillectomy: case-based review.Rheumatol Int. 2019 Jun;39(6):1099-1105. doi: 10.1007/s00296-019-04310-y. Epub 2019 Apr 24. Rheumatol Int. 2019. PMID: 31020337 Review.
Cited by
-
Colchicine versus cimetidine: the better choice for Periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome prophylaxis, and the role of MEFV gene mutations.Pediatr Rheumatol Online J. 2022 Aug 31;20(1):72. doi: 10.1186/s12969-022-00733-3. Pediatr Rheumatol Online J. 2022. PMID: 36045426 Free PMC article. Clinical Trial.
-
Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome in children: a brief literature review.Rev Paul Pediatr. 2022 Jun 10;40:e2021087. doi: 10.1590/1984-0462/2022/40/2021087IN. eCollection 2022. Rev Paul Pediatr. 2022. PMID: 35703722 Free PMC article.
-
Adult-onset Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome Responsive to Colchicine.Intern Med. 2023 Dec 1;62(23):3555-3558. doi: 10.2169/internalmedicine.1364-22. Epub 2023 Apr 14. Intern Med. 2023. PMID: 37062730 Free PMC article.
-
[Colchicine: old medication with new benefits : Use in rheumatology and beyond].Z Rheumatol. 2021 Sep;80(7):647-657. doi: 10.1007/s00393-021-01017-z. Epub 2021 Jun 7. Z Rheumatol. 2021. PMID: 34097101 Free PMC article. German.
-
Independent risk factors for resolution of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome within 4 years after the disease onset.Clin Rheumatol. 2021 May;40(5):1959-1965. doi: 10.1007/s10067-020-05466-w. Epub 2020 Oct 16. Clin Rheumatol. 2021. PMID: 33067771
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials